{"AllianceGenome": "11040", "HGNC": "11040", "MIM": "601843", "_id": "6528", "_version": 1, "accession": {"genomic": ["AB032811.1", "AC005796.1", "AF059566.1", "AJ224353.1", "CH471106.1", "CP068259.2", "MH046063.1", "MN115830.1", "NC_000019.10", "NC_060943.1", "NG_012930.1"], "protein": ["AAB17378.1", "AAC14697.1", "AAC62827.1", "AAF70339.1", "AAI05048.1", "AAI05050.1", "AWM11689.1", "BAA24835.1", "EAW84643.1", "NP_000444.1", "Q92911.1", "QFU28535.1", "XP_011526494.1", "XP_011526495.1", "XP_011526496.1", "XP_016882647.1", "XP_054177777.1", "XP_054177778.1", "XP_054177779.1", "XP_054177780.1"], "rna": ["AF260700.1", "BC105047.1", "BC105049.1", "BX648217.1", "D87920.1", "NM_000453.3", "U66088.1", "XM_011528192.3", "XM_011528193.4", "XM_011528194.4", "XM_017027158.2", "XM_054321802.1", "XM_054321803.1", "XM_054321804.1", "XM_054321805.1"], "translation": [{"protein": "XP_054177779.1", "rna": "XM_054321804.1"}, {"protein": "XP_054177777.1", "rna": "XM_054321802.1"}, {"protein": "XP_054177778.1", "rna": "XM_054321803.1"}, {"protein": "XP_054177780.1", "rna": "XM_054321805.1"}, {"protein": "AAI05050.1", "rna": "BC105049.1"}, {"protein": "AAF70339.1", "rna": "AF260700.1"}, {"protein": "XP_011526496.1", "rna": "XM_011528194.4"}, {"protein": "NP_000444.1", "rna": "NM_000453.3"}, {"protein": "AAI05048.1", "rna": "BC105047.1"}, {"protein": "XP_011526494.1", "rna": "XM_011528192.3"}, {"protein": "XP_016882647.1", "rna": "XM_017027158.2"}, {"protein": "BAA24835.1", "rna": "D87920.1"}, {"protein": "AAB17378.1", "rna": "U66088.1"}, {"protein": "XP_011526495.1", "rna": "XM_011528193.4"}]}, "alias": ["NIS", "TDH1"], "ensembl": {"gene": "ENSG00000105641", "protein": "ENSP00000222248", "transcript": ["ENST00000222248", "ENST00000597109"], "translation": [{"protein": "ENSP00000222248", "rna": "ENST00000222248"}], "type_of_gene": "protein_coding"}, "entrezgene": "6528", "exac": {"_license": "http://bit.ly/2H9c4hg", "all": {"exp_lof": 21.7066449477, "exp_mis": 273.249782364, "exp_syn": 143.465954474, "lof_z": 3.76469393437049, "mis_z": 1.36850500021891, "mu_lof": 1.51844179589e-06, "mu_mis": 2.6416625729e-05, "mu_syn": 1.38154651003e-05, "n_lof": 4.0, "n_mis": 227.0, "n_syn": 132.0, "p_li": 0.740011195140398, "p_null": 2.0814671867698e-05, "p_rec": 0.259967990187734, "syn_z": 0.593453788991294}, "bp": 1932, "cds_end": 18004686, "cds_start": 17983128, "n_exons": 15, "nonpsych": {"exp_lof": 19.3567258296, "exp_mis": 247.027545683, "exp_syn": 129.560651947, "lof_z": 3.4279511074854, "mis_z": 1.5733623778661, "mu_lof": 1.51844179589e-06, "mu_mis": 2.6416625729e-05, "mu_syn": 1.38154651003e-05, "n_lof": 4.0, "n_mis": 198.0, "n_syn": 116.0, "p_li": 0.575088613350279, "p_null": 0.000120566305976751, "p_rec": 0.424790820343744, "syn_z": 0.750082465179939}, "nontcga": {"exp_lof": 19.9418579769, "exp_mis": 251.36156196, "exp_syn": 131.960429561, "lof_z": 3.52157845510666, "mis_z": 1.5511338461151, "mu_lof": 1.51844179589e-06, "mu_mis": 2.6416625729e-05, "mu_syn": 1.38154651003e-05, "n_lof": 4.0, "n_mis": 202.0, "n_syn": 117.0, "p_li": 0.605070783883496, "p_null": 7.67670040160878e-05, "p_rec": 0.394852449112488, "syn_z": 0.824600649637089}, "transcript": "ENST00000222248.3"}, "exons": [{"cdsend": 17893877, "cdsstart": 17872319, "chr": "19", "position": [[17871944, 17872676], [17874137, 17874203], [17874493, 17874545], [17874663, 17874731], [17875951, 17876106], [17877722, 17877863], [17877963, 17878093], [17880864, 17880953], [17881959, 17882072], [17882148, 17882219], [17883680, 17883767], [17883849, 17884046], [17888330, 17888455], [17890885, 17891001], [17893712, 17895174]], "strand": 1, "transcript": "NM_000453", "txend": 17895174, "txstart": 17871944}], "exons_hg19": [{"cdsend": 18004686, "cdsstart": 17983128, "chr": "19", "position": [[17982753, 17983485], [17984946, 17985012], [17985302, 17985354], [17985472, 17985540], [17986760, 17986915], [17988531, 17988672], [17988772, 17988902], [17991673, 17991762], [17992768, 17992881], [17992957, 17993028], [17994489, 17994576], [17994658, 17994855], [17999139, 17999264], [18001694, 18001810], [18004521, 18005983]], "strand": 1, "transcript": "NM_000453", "txend": 18005983, "txstart": 17982753}], "generif": [{"pubmed": 12021185, "text": "iodide symporter gene expression in JAr cells is regulated by human chorionic gonadotropin and by cAMP-dependent and -independent mechanisms; the stimulation of iodide uptake is due to an increase in both mRNA and protein levels"}, {"pubmed": 12039073, "text": "Data show that sodium-iodide symporter promoter/luciferase reporter constructs had increased transcriptional activity after incubation with T3 or RA."}, {"pubmed": 12161518, "text": "A novel peculiar mutation in the sodium/iodide symporter gene in spanish siblings with iodide transport defect."}, {"pubmed": 12351692, "text": "A far-upstream enhancer is important for hNIS regulation in the thyroid. Deficient CRE-like sequence binding protein(s) that bind to the hNUE in normal thyroid cells may be responsible for reduced NIS gene expression in some thyroid carcinomas."}, {"pubmed": 12475396, "text": "observations raise the possibility that NIS expression, and subsequently iodide transport, are reduced in thyroid tumors at least in part owing to alterations in the binding activity of AP2 and Sp1 transcription factors to NIS promoter"}, {"pubmed": 12602914, "text": "Expression of NIS RNA and protein was confirmed by RNAase protection assay, western blot and immunohistochemistry respectively in surgically excised breast tumor tissue (infiltrating duct carcinoma)"}, {"pubmed": 12679487, "text": "sodium iodide symporter is present in many normal epithelial tissues and is predominantly expressed intracellularly in many carcinomas"}, {"pubmed": 12720543, "text": "NIS mRNA levels did not differ in adenomas or carcinomas, compared with normal tissue, and no significant relationship with levels of CREB mRNA was observed."}, {"pubmed": 14630715, "text": "role for APE/Ref-1 protein in the transcriptional regulation of NIS gene expression by itself and in cooperation with PAX8."}, {"pubmed": 15009910, "text": "Rat and human 5' flanking regions in the thyroid share only a 67.8 per cent identity."}, {"pubmed": 15062578, "text": "organification of radioiodide into proteins of thyroid cancer cells exogenously co-expressing TPO and the sodium/iodide symporter (NIS) is strictly dependent of TPO and not of NIS."}, {"pubmed": 15062579, "text": "hNIS promoter and enhancer showed an up to six-fold increase in transcriptional activity after incubation with purified Graves' IgG"}, {"pubmed": 15068624, "text": "that NIS protein expression does not reflect NIS mRNA expression. Therefore, factors that affect targeting of NIS to the plasma membrane are likely to be affected."}, {"pubmed": 15215159, "text": "NIS was found only in malignant thyroid neoplasms and in euthyroid patients; none was found in hypofunctioning thyroid tumors."}, {"pubmed": 15340050, "text": "Nkx-2.5 is a novel relevant transcriptional regulator of mammary NIS"}, {"pubmed": 15472226, "text": "NIS expression is induced by cAMP and/or PI3K in breast cancer both in vivo and in vitro."}, {"pubmed": 15522214, "text": "Data show that tumor cells expressing the thyroidal sodium iodide symporter (NIS) retain iodide longer than thyroid cells due to a combination of slow efflux and reuptake."}, {"pubmed": 15562032, "text": "Hypothyroidism during type I interferon therapy may be related to an abnormal expression and function of key proteins involved in iodine uptake and organification."}, {"pubmed": 15919754, "text": "control of NIS expression by inhibition of histone deacetylases appears not to be mediated by cell-specific mechanisms"}, {"pubmed": 15968416, "text": "Molecular analysis of the expression of the sodium iodide symporter with differentiated thyroid cancer and correlation with scintigraphic findings."}, {"pubmed": 15976004, "text": "G543 residue plays significant roles in NIS maturation and trafficking."}, {"pubmed": 16264365, "text": "NIS gene expression has beneficial effects in human anaplastic thyroid carcinoma cells"}, {"pubmed": 16335670, "text": "Our results suggest that there is no dependence between NIS expression and iodine uptake in thyroid cancers."}, {"pubmed": 16391203, "text": "Our study suggests that NIS will be useful as an imaging reporter gene to ascertain that the therapeutic gene is localized to the correct tissue and to monitor the expression levels and duration of the therapeutic gene."}, {"pubmed": 16954431, "text": "Agents that promote tumor differentiation, or directly stimulate gene expression may result in iodine concentration in 'scan-negative' thyroid cancer and some breast cancer. (review)"}, {"pubmed": 16982034, "text": "These data show for the first time that functional NIS expression is not restricted to lactating mammary gland and malignant breast tissue, but can also be detected in benign breast lesions, such as fibroadenomata of the breast."}, {"pubmed": 16990649, "text": "Recent findings in NIS research that have a direct impact on diagnosis and therapeutic management."}, {"pubmed": 17164311, "text": "Protein synthesis inhibitors, in synergy with 5-azacytidine, restore sodium/iodide symporter gene expression in thyroid cancer cells."}, {"pubmed": 17214887, "text": "Sodium-iodide symporter expression is decreased or absent in cases of intestinalization or malignant transformation of the gastric mucosa."}, {"pubmed": 17297475, "text": "overexpression of PTTG and PBF in differentiated thyroid cancer has profound implications for activity of the NIS gene, and hence significantly impacts upon the efficacy of radioiodine treatment."}, {"pubmed": 17408651, "text": "A significant proportion of human cholangiocarcinomas expresses membrane sodium iodide symporter, which may permit radioiodine therapy. Our data also suggest that (131)I acts on a crucial target for liver cancer development."}, {"pubmed": 17696829, "text": "NIS is adequately expressed and appropriately localized in the thyroid nodule cell membrane from iodine-deficient areas and its expression in vivo is modulated by iodine supply."}, {"pubmed": 17726079, "text": "expression of placental NIS is modulated by maternal iodide"}, {"pubmed": 17854396, "text": "Papillary thyroid cancers Papillary thyroid cancers with no 131I uptake had slightly reduced NIS, significantly reduced thyroglobulin,thyroperoxidase and pendrin and significantly increased GLUT-1 gene expression levels."}, {"pubmed": 17938324, "text": "NIS-L methylation in cancer cells was not associated with methylation in adjacent benign tissue, unlike the other 4 genes."}, {"pubmed": 18187871, "text": "Evaluation of NIS mRNA expression in thyroid tissues may help determine prognoses of Graves' disease patients."}, {"pubmed": 18202121, "text": "CREM is an essential regulator of NIS gene expression."}, {"pubmed": 18339708, "text": "The region of this protein that contains V59 substitution may be involved in intramembrane helix-helix interactions during the transport cycle without being in direct contact with the substrates."}, {"pubmed": 18500672, "text": "cell surface trafficking impairments account for variable cell surface sodium iodide symporter levels in breast cancer"}, {"pubmed": 18509003, "text": "study revealed a significant correlation of BRAFV600E mutation with a lower expression of both sodium iodide symporter and thyroperoxidase in papillary thyroid cancer"}, {"pubmed": 18628528, "text": "Reduced NIS mRNA expression in thyroid malignant nodules is associated with strong intracellular protein staining and may be related to the inability of the NIS protein to migrate to the cellular basolateral membrane."}, {"pubmed": 18708479, "text": "Data first identified the involvement of extracellular charged amino acid residue in the iodide uptake ability of SLC5A5."}, {"pubmed": 19029227, "text": "NIS protein level is low in thyroid and breast cancers and the intracellular staining obtained with anti-NIS antibodies corresponds to a non-specific signal"}, {"pubmed": 19124451, "text": "It seems that lack of hNIS can be useful in distinguishing foveolar hyperplasia from dysplastic glands."}, {"pubmed": 19196800, "text": "Biallelic mutations in the NIS gene lead to a congenital iodide transport defect, an autosomal recessive condition characterized by hypothyroidism, goiter, low thyroid iodide uptake, and a low saliva/plasma iodide ratio."}, {"pubmed": 19241193, "text": "AFP promoter enhancer increased specific expression of the human sodium iodide symporter (hNIS) for targeted radioiodine therapy of hepatocellular carcinoma."}, {"pubmed": 19618116, "text": "The findings of this study indicated that NIS expression is prevalent in breast cancer brain metastases and could have a therapeutic role via the delivery of radioactive iodide and selective ablation of tumor cells."}, {"pubmed": 19706688, "text": "An entirely novel mechanism by which the proto-oncogene PBF binds NIS and alters its subcellular localisation, thereby regulating its ability to uptake iodide, is presented."}, {"pubmed": 19916865, "text": "NIS gene revealed in-frame 6-nucleotide deletion of coding sequence (1206-1211delGTCGGC) corresponding to deletion of amino acids 287 & 288 of human NIS protein located at beginning of VIII transmembrane segment in a family with iodide transport defects."}, {"pubmed": 20153805, "text": "hypothyroidism and goiter due to NIS mutations (Review)"}, {"pubmed": 20213084, "text": "LBH589 is a powerful anti-tumor agent and is able to induce NIS and iodide accumulation in breast cancer cells."}, {"pubmed": 20479570, "text": "Data show that none of the 10 analyzed substances was able to inhibit iodide uptake; only perchlorate and thyocianate were able to inhibit iodide uptake in a dose-dependent manner."}, {"pubmed": 20620544, "text": "Analysis of the effects of iodine 131 on acute cardiac allograft rejection after ex vivo human NIS gene transfer in a rat model of heart allograft."}, {"pubmed": 20797386, "text": "the human sodium/iodide symporter is mainly present in a dimeric form"}, {"pubmed": 20961282, "text": "Functioning thyroid nodules express higher amounts of NIS protein than the extranodular thyroid tissue."}, {"pubmed": 21092238, "text": "Data suggest that conserved charged amino acid residues, except Arg-9, in the extracellular region of the sodium/iodide symporter are critical for iodide transport."}, {"pubmed": 21209020, "text": "This study found that KT5823 decreases iodide uptake within 0.5 h of treatment in trans-retinoic acid and hydrocortisone-treated MCF-7 breast cancer cells, but increases iodide uptake in thyroid cells."}, {"pubmed": 21428212, "text": "hNIS was present in high frequency as demonstrated by immunohistochemistry in fibroadenoma breast."}, {"pubmed": 21521301, "text": "NIS expression in differentiated thyroid carcinomas may help characterize patients' risk and individuals with a poor response to therapy, but is not useful as a diagnostic or prognostic marker."}, {"pubmed": 21587211, "text": "Our data demonstrate the high potential of genetically engineered mesenchymal stem cells as tumor-selective delivery vehicles for the human NIS gene after systemic application."}, {"pubmed": 21702220, "text": "sodium iodide symporter expression was positive in 41.66% of breast carcinoma tumor regions versus none in the normal breast tissue regions"}, {"pubmed": 21988488, "text": "The expression of human sodium/iodide symporter fusion gene was confirmed in transfected cells using RT-PCR and Western blotting."}, {"pubmed": 21989446, "text": "In thyroid carcinomas, NIS mRNA levels were lower but the proteins were overexpressed. The NIS protein mainly locates in the cytoplasm, which therefore lacks the ability of transporting and absorbing iodine."}, {"pubmed": 22157753, "text": "Overexpression of p38beta or Rac1 significantly enhanced (1.9- and 3.9-fold, respectively), the tRA-stimulated NIS expression in MCF-7 cells."}, {"pubmed": 22510021, "text": "CREM expression is increased in thyroid cancer tissue and may play a role in the downregulation of sodium iodide symporter expression in thyroid cancer acting at the transcriptional level"}, {"pubmed": 22545753, "text": "analysis of subcellular distribution of the sodium iodide symporter in benign and malignant thyroid tissues"}, {"pubmed": 22781452, "text": "Nevirapine may induce the up-regulation of NIS mRNA and TSHR mRNA in FRO anaplastic thyroid carcinoma cells."}, {"pubmed": 22954554, "text": "Data indicate that expression of SLC5A5 in placenta is up-regulated during placentation; during the first trimester, SLC5A5 mRNA is low at 6 weeks and peaks at 12 weeks; expression of SLC5A5 protein increases with increased placental vascularization."}, {"pubmed": 22962269, "text": "our results established NIS as a carrier protein that interacts with a major cell signaling hub to facilitate tumor cell locomotion and invasion."}, {"pubmed": 22982218, "text": "Data from various thyroid cancer cell lines suggest that PARP (poly(ADP-ribose) polymerase) inhibition increases NIS gene expression through a particular modulation of transcriptional regulatory mechanisms (i.e., specific histone modifications)."}, {"pubmed": 23117572, "text": "Sodium/iodide symporter is expressed in the majority of seminomas and embryonal testicular carcinomas."}, {"pubmed": 23134812, "text": "Data indicate that MV-NIS, an oncolytic measles virus that encodes the human thyroidal sodium iodide symporter (NIS), deliver targeted radiotherapy to the tumor site and promote a localized bystander effect. above and beyond that achieved by MV alone."}, {"pubmed": 23163107, "text": "The BRAF(V600E) mutation was associated with a statistically significant lower functional NIS protein expression in the classic variant of papillary thyroid carcinomas."}, {"pubmed": 23174149, "text": "NIS is highly expressed in early human trophoblast at the feto-maternal interface."}, {"pubmed": 23255420, "text": "Molecular imaging of luciferase signal and sodium-iodide symporter imaging may be useful for in vivo optimization of bioenergetics in transplanted cells."}, {"pubmed": 23342072, "text": "The study indicates a positive link between hNIS and ER expression in breast cancer."}, {"pubmed": 23404856, "text": "MEK inhibition leads to lysosome-mediated NIS protein degradation in human breast cancer cells"}, {"pubmed": 23441638, "text": "NIS expression is tightly modulated during the transition of intercalated to striated ducts and striated to excretory ducts in salivary ductal cells. NIS expression in salivary glands is decreased during inflammation and tumor formation"}, {"pubmed": 23650190, "text": "Data indicate that interhelical interaction is required for Na(+)/I(-) symporter (NIS) folding and activity."}, {"pubmed": 23678037, "text": "Data from mutant recombinant proteins suggest that proto-oncogene PBF/PTTG1IP (pituitary tumor-transforming 1 interacting protein) is phosphoprotein and highlight importance of tyrosine residue Y174 in its interaction/co-localization with NIS."}, {"pubmed": 23690546, "text": "The results suggest a a key structural role for the delta-amino group of R124 in the Na+/I- symporter's maturation and cell surface targeting."}, {"pubmed": 23857380, "text": "Data indicate that Na+/I- symporter and type 3 iodothyronine deiodinase genes are expressed in term placenta and amniotic membrane."}, {"pubmed": 23988430, "text": "SLC5A5 is composed of 13 transmembrane helices and 643 amino acid residues in humans. (Review)"}, {"pubmed": 24052075, "text": "the NIS gene is a direct target of the p53 family."}, {"pubmed": 24096868, "text": "Due to their low NIS expression, TCV and DSPTC need higher cumulative doses of radioactive iodine therapy to improve their prognosis."}, {"pubmed": 24353283, "text": "The expression of TSHR and NIS genes is differently controlled by multiple mechanisms, including epigenetic events elicited by major signaling pathways involved in thyroid tumorigenesis."}, {"pubmed": 24432988, "text": "this study identified a new distal enhancer, NIS distal enhancer, that regulates gene expression through DNA methylation in thyroid cancer."}, {"pubmed": 24708099, "text": "NIS is a new ovarian cancer marker, opening a door for the use of radioiodide in the diagnosis and treatment of ovarian cancer patients."}, {"pubmed": 24884806, "text": "Given the recent progress in the study of NIS regulation as molecular basis for new therapeutic approaches in extrathyroidal cancers."}, {"pubmed": 24888603, "text": "Although the affinity of NIS for I- is low, it increases when Na+ is bound. NIS takes advantage of the extracellular Na+ concentration and the pronounced increase in its own affinity for I- and for the second Na+ elicited by binding of the first."}, {"pubmed": 25199743, "text": "In normal salivary gland, striated duct cells strongly expressed NIS. In Warthin's tumors, eosinophilic epithelial cells exhibited NIS expression, but expression was varied among cases.  Tc-positive specimens were NIS+. Tc-negative specimens were NIS-."}, {"pubmed": 25378232, "text": "BRAF V600E inhibited NIS expression by the upregulation of its promoter methylation.  Specific regions of CpG islands of NIS promoter in BRAF V600E harboring papillary thyroid carcinoma were highly methylated compared with surrounding normal tissue."}, {"pubmed": 25465605, "text": "results indicate that the NIS mutation rate is very low in the Guangxi Zhuang Region, China, and it is necessary to study mutations of other genes that have major effects on thyroid dyshormonogenesis and have not as yet been studied in this population."}, {"pubmed": 25842835, "text": "Relatively weak melanoma-specific promoter directs high NIS activity in melanoma cell, however weaker cancer-specific promoters drive high NIS activity only in certain melanoma cell line."}, {"pubmed": 25955347, "text": "Our results confirmed that NIS overexpression enhances the sensitivity of ER-negative breast cancer cells to radioiodide therapy."}, {"pubmed": 25960292, "text": "concluded that NIS-mediated RAIU could be modulated by miR-146b; accordingly, miR-146b might serve as one of targets to enhance efficacy of radioactive therapy against poorly differential thyroid carcinoma"}, {"pubmed": 26160439, "text": "Study demonstrates an association of one variant and several haplotypes of the NIS gene with differentiated thyroid cancer."}, {"pubmed": 26213306, "text": "Real time PCR revealed that both cell lines express mRNA of lactoferrin receptors while flow cytometry and confocal microscopy showed the cells efficiently internalize bLf which upregulates NIS expression."}, {"pubmed": 26282166, "text": "miR-146b-3p binds to the 3'-untranslated region of PAX8 and sodium/iodide symporter, leading to impaired protein translation and a subsequent reduction in iodide uptake."}, {"pubmed": 26285906, "text": "Data suggest that SLC5A5, SLC5A8 (sodium-coupled monocarboxylate transporter 1), and SLC26A4 (pendrin), the 3 known iodide transporters, are important in breast tissue metabolism in lactation and in breast neoplasms. [REVIEW]"}, {"pubmed": 26599396, "text": "Therefore, enhancing functional NIS by the increasing level of glycosylation may be suggested as a promising therapeutic strategy for cancer patients who show refractory response to conventional radioiodine treatment."}, {"pubmed": 26831514, "text": "Mutating the sites located on the C-terminal domain of the protein has no effect except for the creation of a diacidic motif that decreases the total NIS protein level without affecting its expression at the plasma membrane."}, {"pubmed": 26960757, "text": "SLC5A5 was down-regulated in FTC and PTC. Its expression could be modulated by hsa-let-7f-5p. ATC showed a loss of SLC5A5/hsa-let7f-5p correlation"}, {"pubmed": 27363025, "text": "Data indicate that although fewer than 25% of cells expressed Na+/I- symporter (NIS), combining131I- with gemcitabine (GEMGEM/131I)- caused dramatic tumor regression in NIS-transduced breast cancer brain metastases (BCBMs)."}, {"pubmed": 27458162, "text": "Results show transgene induction under hypoxia in tumor cell spheroid models, or radioiodide uptake using sodium iodide symporter (NIS)."}, {"pubmed": 27562170, "text": "Experiments in whole cells demonstrated that these four residues participate in transport by NIS: mutations at these positions result in proteins that, although expressed at the plasma membrane, transport little or no I(-) These residues are conserved throughout the entire SLC5 family, to which NIS belongs, suggesting that they serve a similar function in the other transporters"}, {"pubmed": 27573304, "text": "Our findings indicated that hTERT promoter-driven expression of the NIS gene in HeLa cells led to 188Re uptake and therapeutic effects. Thus, NIS-based gene therapy and imaging using the hTERT promoter and 188Re may be possible."}, {"pubmed": 28190186, "text": "NIS localization in the follicular lumen in nodular goiter patients"}, {"pubmed": 28361851, "text": "Results indicate that Na+/I- symporter (NIS) can be used as an objective used as an objective criterion for determining the sensitivity of luminal B and basal breast cancer (BC)subtypes to neoadjuvant chemotherapy (NACT)."}, {"pubmed": 28396984, "text": "Data suggest iodination of TG is involved in regulation of NIS expression in thyroid follicle via TSH/TSHR signaling; NIS expression and PKA activity are up-regulated by lowly iodinated TG; NIS expression is down-regulated and PKC activity up-regulated by highly iodinated TG. (TG, thyroglobulin; NIS, sodium/iodide symporter; PK, protein kinase; TSH, thyroid-stimulating hormone; TSHR, thyroid-stimulating hormone receptor)"}, {"pubmed": 28493972, "text": "radiotracer accumulation in transfected cells correlated with the induction of hNIS and with the expression of miRNAs detected by real time PCR."}, {"pubmed": 28528452, "text": "Study brings out molecular evidence showing that NIS is a direct target of wild-type p53 and its activation upon Doxorubicin drug exposure results in suppression of NIS expression and function in breast cancer cells."}, {"pubmed": 29131623, "text": "The present work reveals much lower iodide affinity in the pocket of human SMCT1 analogous to the putative iodide-binding pocket of human NIS."}, {"pubmed": 29631680, "text": "The expression of NIS differs insignificantly in gastric tissue of obese and control individuals."}, {"pubmed": 29772533, "text": "Pendrin residues which are mutated in Pendred's syndrome are identical to those in the aligned position of sodium/iodide symporter (NIS) and apical iodide transporter (AIT)."}, {"pubmed": 29978611, "text": "Expression of SLC5A5 mRNA was negatively correlated with SLC2A1 mRNA. This finding provides a molecular basis for the management of PTC with negative WBS using F-FDG PET scans. In addition, higher expression of SLC5A5 mRNA was associated with less PTC [papillary thyroid cancer] recurrence, but not with deaths."}, {"pubmed": 30053080, "text": "Low NIS glycosylation is associated with Papillary Thyroid Carcinoma."}, {"pubmed": 30191346, "text": "High sodium-iodide symporter expression is associated with gastric cancer."}, {"pubmed": 30217930, "text": "NIS has a role in thyroid cancer cells that involves PTEN signaling"}, {"pubmed": 30496374, "text": "The intracellularly facing carboxy-terminus of NIS is required for the transport of the protein to the plasma membrane."}, {"pubmed": 31119602, "text": "The data suggest that via inhibition of BCL-2 expression, overexpressed NES1 might enhance the effect of radiation therapy of (131)I uptake in hNIS overexpressed PC3 cells."}, {"pubmed": 31196853, "text": "Radiation-Induced Amplification of TGFB1-Induced Mesenchymal Stem Cell-Mediated Sodium Iodide Symporter (NIS) Gene (131)I Therapy."}, {"pubmed": 31310151, "text": "Dimerization of the Sodium/Iodide Symporter."}, {"pubmed": 31331356, "text": "Acting as a critical regulator of autophagy-mediated NIS degradation via ROS/AMPK/mTOR pathway, HMGB1is a potential intervention target of radioiodine therapy in thyroid cancer."}, {"pubmed": 31455607, "text": "this study shows the important role of mannosidase in N-glycosylation processing in order to correctly traffic NIS to the plasma membrane in breast cancer cells."}, {"pubmed": 31672844, "text": "Study identified two novel sodium iodide symporter (NIS) interactors, valosin-containing protein (VCP) and ADP-ribosylation factor 4 (ARF4), with critical roles in modulating NIS function as well as correlating markedly with clinical outcome in papillary thyroid cancer. ARF4 enhanced NIS vesicular trafficking from the Golgi to the plasma membrane, whereas VCP governed NIS proteolysis."}, {"pubmed": 31922240, "text": "Iodine131 metabolic radiotherapy leads to cell death and genomic alterations through NIS overexpression on cholangiocarcinoma."}, {"pubmed": 32451489, "text": "Allosteric regulation of mammalian Na(+)/I(-) symporter activity by perchlorate."}, {"pubmed": 33031052, "text": "Clinical characteristics, surgical approach, BRAFV600E mutation and sodium iodine symporter expression in pediatric patients with thyroid carcinoma."}, {"pubmed": 33293661, "text": "Network analysis reveals essential proteins that regulate sodium-iodide symporter expression in anaplastic thyroid carcinoma."}, {"pubmed": 33779310, "text": "The Iodide Transport Defect-Causing Y348D Mutation in the Na(+)/I(-) Symporter Renders the Protein Intrinsically Inactive and Impairs Its Targeting to the Plasma Membrane."}, {"pubmed": 34196428, "text": "The PDZ protein SCRIB regulates sodium/iodide symporter (NIS) expression at the basolateral plasma membrane."}, {"pubmed": 34387194, "text": "The complex regulation of NIS expression and activity in thyroid and extrathyroidal tissues."}, {"pubmed": 34514854, "text": "Impact of the Mutational Landscape of the Sodium/Iodide Symporter in Congenital Hypothyroidism."}, {"pubmed": 34726525, "text": "An Intramolecular Ionic Interaction Linking Defective Sodium/Iodide Symporter Transport to the Plasma Membrane and Dyshormonogenic Congenital Hypothyroidism."}, {"pubmed": 34806438, "text": "Brief Report: A Novel Sodium/Iodide Symporter Mutation, S356F, Causing Congenital Hypothyroidism."}, {"pubmed": 34840979, "text": "Downregulation of Rap1GAP Expression Activates the TGF-beta/Smad3 Pathway to Inhibit the Expression of Sodium/Iodine Transporter in Papillary Thyroid Carcinoma Cells."}, {"pubmed": 35600585, "text": "Silent but Not Harmless: A Synonymous SLC5A5 Gene Variant Leading to Dyshormonogenic Congenital Hypothyroidism."}, {"pubmed": 35607818, "text": "Seaweed and Iodine Intakes and SLC5A5 rs77277498 in Relation to Thyroid Cancer."}, {"pubmed": 36214955, "text": "The effect of sodium iodide symporter protein on ablation success in patients with differentiated thyroid cancer."}], "genomic_pos": {"chr": "19", "end": 17895174, "ensemblgene": "ENSG00000105641", "start": 17871945, "strand": 1}, "genomic_pos_hg19": {"chr": "19", "end": 18005983, "start": 17982782, "strand": 1}, "go": {"BP": [{"evidence": "TAS", "gocategory": "BP", "id": "GO:0006590", "qualifier": "involved_in", "term": "thyroid hormone generation"}, {"evidence": "TAS", "gocategory": "BP", "id": "GO:0006811", "qualifier": "involved_in", "term": "monoatomic ion transport"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:0006814", "qualifier": "involved_in", "term": "sodium ion transport"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:0015705", "pubmed": 12021185, "qualifier": "involved_in", "term": "iodide transport"}, {"evidence": "IEA", "gocategory": "BP", "id": "GO:0035725", "qualifier": "involved_in", "term": "sodium ion transmembrane transport"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0071320", "pubmed": 12021185, "qualifier": "involved_in", "term": "cellular response to cAMP"}, {"evidence": "IEP", "gocategory": "BP", "id": "GO:0071371", "pubmed": 12021185, "qualifier": "involved_in", "term": "cellular response to gonadotropin stimulus"}, {"evidence": "NAS", "gocategory": "BP", "id": "GO:0150104", "pubmed": 30280653, "qualifier": "involved_in", "term": "transport across blood-brain barrier"}, {"evidence": "IBA", "gocategory": "BP", "id": "GO:1904200", "qualifier": "involved_in", "term": "iodide transmembrane transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1904200", "pubmed": [21988488, 26599396], "qualifier": "involved_in", "term": "iodide transmembrane transport"}, {"evidence": "IMP", "gocategory": "BP", "id": "GO:1904200", "pubmed": 26831514, "qualifier": "involved_in", "term": "iodide transmembrane transport"}, {"evidence": "ISS", "gocategory": "BP", "id": "GO:1904200", "qualifier": "involved_in", "term": "iodide transmembrane transport"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1904322", "pubmed": 9329364, "qualifier": "involved_in", "term": "cellular response to forskolin"}, {"evidence": "IDA", "gocategory": "BP", "id": "GO:1904401", "pubmed": 9329364, "qualifier": "involved_in", "term": "cellular response to Thyroid stimulating hormone"}], "CC": [{"evidence": "IDA", "gocategory": "CC", "id": "GO:0005634", "pubmed": 15961562, "qualifier": "located_in", "term": "nucleus"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005737", "pubmed": 18372236, "qualifier": "located_in", "term": "cytoplasm"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005886", "pubmed": [21988488, 26831514], "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IC", "gocategory": "CC", "id": "GO:0005886", "pubmed": 21988488, "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": 26599396, "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "IDA", "gocategory": "CC", "id": "GO:0005886", "pubmed": [18372236, 20797386, 26599396], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "IMP", "gocategory": "CC", "id": "GO:0005886", "pubmed": [18708479, 31310151], "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "is_active_in", "term": "plasma membrane"}, {"evidence": "ISS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0005886", "qualifier": "located_in", "term": "plasma membrane"}, {"evidence": "TAS", "gocategory": "CC", "id": "GO:0016020", "pubmed": 9388506, "qualifier": "located_in", "term": "membrane"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:0070062", "pubmed": 19199708, "qualifier": "located_in", "term": "extracellular exosome"}, {"evidence": "HDA", "gocategory": "CC", "id": "GO:1903561", "pubmed": 24769233, "qualifier": "located_in", "term": "extracellular vesicle"}], "MF": [{"category": "MF", "evidence": "IPI", "id": "GO:0005515", "pubmed": 32296183, "qualifier": "enables", "term": "protein binding"}, {"category": "MF", "evidence": "IBA", "id": "GO:0008507", "qualifier": "enables", "term": "sodium:iodide symporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0008507", "pubmed": [8806637, 9329364, 12488351, 18372236, 20797386, 32084174], "qualifier": "enables", "term": "sodium:iodide symporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0008507", "pubmed": [18708479, 31310151], "qualifier": "enables", "term": "sodium:iodide symporter activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0008507", "qualifier": "enables", "term": "sodium:iodide symporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015111", "pubmed": [21988488, 26599396], "qualifier": "enables", "term": "iodide transmembrane transporter activity"}, {"category": "MF", "evidence": "IMP", "id": "GO:0015111", "pubmed": [12021185, 26831514], "qualifier": "enables", "term": "iodide transmembrane transporter activity"}, {"category": "MF", "evidence": "ISS", "id": "GO:0015111", "qualifier": "enables", "term": "iodide transmembrane transporter activity"}, {"category": "MF", "evidence": "TAS", "id": "GO:0015111", "qualifier": "enables", "term": "iodide transmembrane transporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0015373", "pubmed": 12488351, "qualifier": "enables", "term": "monoatomic anion:sodium symporter activity"}, {"category": "MF", "evidence": "IDA", "id": "GO:0042803", "pubmed": [18372236, 20797386, 31310151], "qualifier": "enables", "term": "protein homodimerization activity"}]}, "homologene": {"genes": [[7955, 561445], [8364, 100144711], [9031, 431544], [9598, 468767], [9606, 6528], [9615, 484830], [9913, 505310], [10090, 114479], [10116, 114613]], "id": 37311}, "interpro": [{"desc": "Sodium/solute symporter", "id": "IPR001734", "short_desc": "Na/solute_symporter"}, {"desc": "Sodium/solute symporter, conserved site", "id": "IPR018212", "short_desc": "Na/solute_symporter_CS"}, {"desc": "Sodium/iodide cotransporter", "id": "IPR035689", "short_desc": "SLC5A5"}, {"desc": "Sodium/glucose symporter superfamily", "id": "IPR038377", "short_desc": "Na/Glc_symporter_sf"}], "ipi": "IPI00024248", "map_location": "19p13.11", "name": "solute carrier family 5 member 5", "other_names": ["Na(+)/I(-) cotransporter", "Na(+)/I(-) symporter", "natrium iodide transporter", "sodium/iodide cotransporter", "solute carrier family 5 (sodium iodide symporter), member 5", "solute carrier family 5 (sodium/iodide cotransporter), member 5"], "pantherdb": {"HGNC": "11040", "_license": "http://pantherdb.org/tou.jsp", "ortholog": [{"MGI": "2149330", "ortholog_type": "LDO", "panther_family": "PTHR42985", "taxid": 10090, "uniprot_kb": "Q99PN0"}, {"RGD": "69267", "ortholog_type": "LDO", "panther_family": "PTHR42985", "taxid": 10116, "uniprot_kb": "Q63008"}, {"Ensembl": "ENSGALG00000041932", "ortholog_type": "LDO", "panther_family": "PTHR42985", "taxid": 9031, "uniprot_kb": "A0A3Q2UFU3"}, {"ZFIN": "ZDB-GENE-060503-585", "ortholog_type": "LDO", "panther_family": "PTHR42985", "taxid": 7955, "uniprot_kb": "A4IG60"}, {"WormBase": "WBGene00014092", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 6239, "uniprot_kb": "Q23616"}, {"FlyBase": "FBgn0052669", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "P83740"}, {"FlyBase": "FBgn0034494", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q8SWV5"}, {"FlyBase": "FBgn0037895", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9VGP3"}, {"FlyBase": "FBgn0250757", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9VBK1"}, {"FlyBase": "FBgn0029950", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9W3R0"}, {"FlyBase": "FBgn0051262", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q8IN99"}, {"FlyBase": "FBgn0053124", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9VQ85"}, {"FlyBase": "FBgn0051668", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q8IPY0"}, {"FlyBase": "FBgn0031998", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9VLR8"}, {"FlyBase": "FBgn0035293", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q961Q9"}, {"FlyBase": "FBgn0039872", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9V9U2"}, {"FlyBase": "FBgn0039873", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "Q9V9U1"}, {"FlyBase": "FBgn0017448", "ortholog_type": "O", "panther_family": "PTHR42985", "taxid": 7227, "uniprot_kb": "P91659"}], "uniprot_kb": "Q92911"}, "pathway": {"kegg": {"id": "hsa04918", "name": "Thyroid hormone synthesis - Homo sapiens (human)"}, "netpath": {"id": "Pathway_EGFR1", "name": "EGFR1"}, "reactome": [{"id": "R-HSA-1430728", "name": "Metabolism"}, {"id": "R-HSA-1643685", "name": "Disease"}, {"id": "R-HSA-209776", "name": "Metabolism of amine-derived hormones"}, {"id": "R-HSA-209968", "name": "Thyroxine biosynthesis"}, {"id": "R-HSA-382551", "name": "Transport of small molecules"}, {"id": "R-HSA-425393", "name": "Transport of inorganic cations/anions and amino acids/oligopeptides"}, {"id": "R-HSA-425407", "name": "SLC-mediated transmembrane transport"}, {"id": "R-HSA-428643", "name": "Organic anion transporters"}, {"id": "R-HSA-5619096", "name": "Defective SLC5A5 causes thyroid dyshormonogenesis 1 (TDH1)"}, {"id": "R-HSA-5619102", "name": "SLC transporter disorders"}, {"id": "R-HSA-5619115", "name": "Disorders of transmembrane transporters"}, {"id": "R-HSA-71291", "name": "Metabolism of amino acids and derivatives"}], "smpdb": {"id": "SMP00716", "name": "Thyroid hormone synthesis"}, "wikipathways": [{"id": "WP1981", "name": "Thyroxine (Thyroid Hormone) Production"}, {"id": "WP2882", "name": "Nuclear Receptors Meta-Pathway"}, {"id": "WP2884", "name": "NRF2 pathway"}, {"id": "WP4746", "name": "Thyroid hormones production and their peripheral downstream signaling effects"}, {"id": "WP4917", "name": "Proximal tubule transport"}]}, "pfam": "PF00474", "pharmgkb": "PA35905", "pharos": {"target_id": 12202, "tdl": "Tbio"}, "pir": "JC4974", "prosite": "PS50283", "reagent": {"GNF_Qia_hs-genome_v1_siRNA": [{"id": "GNF256403", "relationship": "is"}, {"id": "GNF256404", "relationship": "is"}, {"id": "GNF256405", "relationship": "is"}, {"id": "GNF256406", "relationship": "is"}], "GNF_hs-druggable_lenti-shRNA": [{"id": "GNF090944", "relationship": "is"}, {"id": "GNF090945", "relationship": "is"}], "GNF_hs-druggable_plasmid-shRNA": [{"id": "GNF053685", "relationship": "is"}, {"id": "GNF058457", "relationship": "is"}, {"id": "GNF073683", "relationship": "is"}, {"id": "GNF078871", "relationship": "is"}], "GNF_hs-druggable_siRNA": [{"id": "GNF070039", "relationship": "is"}, {"id": "GNF070040", "relationship": "is"}], "GNF_mm+hs-MGC": [{"id": "GNF279276", "relationship": "is"}, {"id": "GNF279278", "relationship": "is"}], "NOVART_hs-genome_siRNA": [{"id": "GNF103716", "relationship": "is"}, {"id": "GNF143366", "relationship": "is"}]}, "refseq": {"genomic": ["NC_000019.10", "NC_060943.1", "NG_012930.1"], "protein": ["NP_000444.1", "XP_011526494.1", "XP_011526495.1", "XP_011526496.1", "XP_016882647.1", "XP_054177777.1", "XP_054177778.1", "XP_054177779.1", "XP_054177780.1"], "rna": ["NM_000453.3", "XM_011528192.3", "XM_011528193.4", "XM_011528194.4", "XM_017027158.2", "XM_054321802.1", "XM_054321803.1", "XM_054321804.1", "XM_054321805.1"], "translation": [{"protein": "XP_054177779.1", "rna": "XM_054321804.1"}, {"protein": "XP_054177777.1", "rna": "XM_054321802.1"}, {"protein": "XP_054177778.1", "rna": "XM_054321803.1"}, {"protein": "XP_054177780.1", "rna": "XM_054321805.1"}, {"protein": "NP_000444.1", "rna": "NM_000453.3"}, {"protein": "XP_011526496.1", "rna": "XM_011528194.4"}, {"protein": "XP_011526494.1", "rna": "XM_011528192.3"}, {"protein": "XP_016882647.1", "rna": "XM_017027158.2"}, {"protein": "XP_011526495.1", "rna": "XM_011528193.4"}]}, "reporter": {"HG-U133_Plus_2": "211123_at", "HG-U95Av2": "32459_at", "HTA-2_0": "TC19000346.hg.1", "HuEx-1_0": "3824623", "HuGene-1_1": "8026877", "HuGene-2_1": "16859657"}, "summary": "This gene encodes a member of the sodium glucose cotransporter family. The encoded protein is responsible for the uptake of iodine in tissues such as the thyroid and lactating breast tissue. The iodine taken up by the thyroid is incorporated into the metabolic regulators triiodothyronine (T3) and tetraiodothyronine (T4). Mutations in this gene are associated with thyroid dyshormonogenesis 1.[provided by RefSeq, Sep 2009].", "symbol": "SLC5A5", "taxid": 9606, "type_of_gene": "protein-coding", "umls": {"cui": "C1420204"}, "unigene": "Hs.584804", "uniprot": {"Swiss-Prot": "Q92911"}, "wikipedia": {"url_stub": "Sodium-iodide symporter"}}